Evidence map›Paper›PMID 18797620›Full record

ArticleBulletin of the World Health Organization2008

Ethical analysis to improve decision-making on health technologies.

Samuli I Saarni, Bjørn Hofmann, Kristian Lampe, Dagmar Lühmann, Marjukka Mäkelä, Marcial Velasco-Garrido, Ilona Autti-Rämö

Open access · diamondAbstract read
In one paragraph

Article in Bulletin of the World Health Organization, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 1 pooled it
27.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 1 synthesis or guideline pooled it, 102 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. A survey of national ethics and bioethics committees.Bulletin of the World Health Organization · 2021
    Article
  5. Evidence-Based Decision Making 3: Health Technology Assessment.Methods in molecular biology (Clifton, N.J.) · 2021
    Article
  6. Article
  7. Review
  8. Transformation of the Doctor-Patient Relationship: Big Data, Accountable Care, and Predictive Health Analytics.HEC forum : an interdisciplinary journal on hospitals' ethical and legal issues · 2019
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Do ethical considerations influence any in HTA reports? A review of reports.Medical journal of the Islamic Republic of Iran · 2016
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Samuli I SaarniFinnish Office for Health Technology Assessment, National Research and Development Centre for Welfare and Health, Helsinki, Finland. samuli.saarni@helsinki.fi
Bjørn Hofmann
Kristian Lampe
Dagmar Lühmann
Marjukka Mäkelä
Marcial Velasco-Garrido
Ilona Autti-Rämö
Finnish Institute for Health and Welfare · FI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Health technology assessment (HTA) is the multidisciplinary study of the implications of the development, diffusion and use of health technologies. It supports health-policy decisions by providing a joint knowledge base for decision-makers. To increase its policy relevance, HTA tries to extend beyond effectiveness and costs to also considering the social, organizational and ethical implications of technologies. However, a commonly accepted method for analysing the ethical aspects of health technologies is lacking. This paper describes a model for ethical analysis of health technology that is easy and flexible to use in different organizational settings and cultures. The model is part of the EUnetHTA project, which focuses on the transferability of HTAs between countries. The EUnetHTA ethics model is based on the insight that the whole HTA process is value laden. It is not sufficient to only analyse the ethical consequences of a technology, but also the ethical issues of the whole HTA process must be considered. Selection of assessment topics, methods and outcomes is essentially a value-laden decision. Health technologies may challenge moral or cultural values and beliefs, and their implementation may also have significant impact on people other than the patient. These are essential considerations for health policy. The ethics model is structured around key ethical questions rather than philosophical theories, to be applicable to different cultures and usable by non-philosophers. Integrating ethical considerations into HTA can improve the relevance of technology assessments for health care and health policy in both developed and developing countries.

Indexed as

Decision Making, OrganizationalHealth PolicyInternationalityModels, OrganizationalAttitude to HealthCost-Benefit AnalysisCultureDiffusion of InnovationEthical AnalysisHumansInterdisciplinary CommunicationMoralsPilot ProjectsProgram EvaluationSocial ResponsibilitySocial Values

Identifiers

PMID18797620
PMCPMC2649462
OpenAlexW2136827796

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.